GPER1 and colonic neoplasm: Pre-treatment with NF449 or the adenylyl cyclase inhibitor SQ 22,536 before GPER1 activation restored elevated cAMP to baseline levels, confirming a GPER1-Gαs-adenylyl cyclase signaling axis in our colon cancer cell system (Supplementary Fig. 1c).